| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,814,622 | 8,136,401 | 7,057,070 | | Cost of Revenue | 2,648,499 |
-
| 3,081,272 | | | Gross Profit | 3,166,123 | 8,136,401 | 3,975,798 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,280,378 | 5,572,866 | 1,907,967 | | Non Recurring | 636,642 | 57,323 |
-
| | Others | 1,740,376 | 2,473,057 | 2,048,631 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (491,272) | 33,155 | 19,199 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (147,251) | 37,749 | (170,246) | | Earnings Before Interest And Taxes | (617,674) | 106,256 | (126,558) | | Interest Expense | 714,249 | 1,027,012 | 896,092 | | Income Before Tax | (1,331,923) | (920,755) | (1,022,650) | | Income Tax Expense | (9,846) | 4,993 | (23,117) | | Minority Interest | (1,014) |
-
| 1,959 | | | | Net Income From Continuing Ops | (1,323,091) | (925,749) | (997,574) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 15,477 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (63,867) | | Other Items |
-
|
-
|
-
| | | | Net Income | (1,323,091) | (925,749) | (1,045,963) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,323,091) | ($925,749) | ($1,045,963) |
|
0.37% Nasdaq 
Income Statement
